Once a common wild plant growing everywhere, Macleaya cordata has now achieved a value leap through its extract, becoming a hot product in the global plant extract market and a core choice for replacing antibiotics in animal husbandry.
Derived from a traditional medicinal plant, this extract is rich in active alkaloids such as sanguinarine and chelerythrine. It possesses multiple effects including broad-spectrum antibacterial, anti-inflammatory, and gut-regulating properties, with no drug residue and low risk of drug resistance, perfectly aligning with the global trend of “reducing and banning antibiotics”. As China’s first Class II new veterinary Chinese medicine raw material for disease prevention and growth promotion, it has been widely used in livestock and poultry breeding, and is gradually expanding to fields such as agricultural plant protection and topical personal care products.
With its core advantage of green and safety, Macleaya cordata extract has not only passed 566 pesticide residue tests by the EU and successfully entered the international market, but also achieved the transformation from a wild mountain herb to a high-value industrial raw material. It has become a potential category in plant-derived raw material exports in recent years, providing a remarkable example for the modernization and development of traditional plant resources.